GSK3-IN-3

GSK3-IN-3 is a mitophagy inducer, inducing Parkin-dependent mitophagy . GSK3-IN-3 is also a GSK-3 inhibitor with an IC 50 value of 3.01 μM. GSK3-IN-3 is non-ATP nor substrate competitive and is neuroprotective against 6-OHDA In Vitro GSK3-IN-3 (VP07) (25 μM; 24 h) induces mitophagy in Parkin-expressing U2OS-iMLS cells with restricted potency. GSK3-IN-3 (1.56-25 μM; 24 h) results in mitochondria fission with mitochondrial morphology change in U2OS-iMLS-Parkin cells. GSK3-IN-3 (VP0.7) (5 μM, 10 μM; ) shows neuroprotection against 6-OHDA albeit in a Parkinson's disease in vitro cellular model in SH-SY5Y cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only. ImmunofluorescenceCell Line: Parkin-expressing U2OS-iMLS cells Concentration: 1.56 μM, 3.12 μM, 6.25 μM, 12.5 μM, and 25 μM; Incubation Time: 24 hours Result: Induced a mitochondrial morphology change from a filament-shaped network to a more round-shaped network. Cell Viability AssayCell Line: SH-SY5Y cells Concentration: 0.5 μM, 1 μM, 3 μM, 5 μM, and 10 μM Incubation Time: 16 hours; with 35 μM 6-OHDA Result: Inhibited cell growth with an IC 50 value of 2.57 μM. Form:Solid IC50& Target:IC50: 3.01 μM (GSK-3)

No numbering system information yet

No physical and chemical property information yet

No safety information yet

No production method and use information yet

No upstream information yet

No downstream information yet

No related product information yet